1 / 6
Laboratory Research Material
Pancragen
20 mg per vial · Lyophilized powder
Laboratory Research Material
Pancragen 20 mg per vial
$54.99
- Compound
- Pancragen
- Amount per vial
- 20 mg
- Form
- Lyophilized powder
- Packaging
- 1 × 3 mL vial, boxed
- Shipping
- FedEx 2DayShips from the U.S. Estimated arrival2 business days after dispatchWeekday dispatch · 4 p.m. ET cutoff
Delivery details
Estimated for in-stock orders using FedEx 2Day. Weekends and FedEx closures are excluded. Holiday pickups, destination and carrier delays can affect arrival. Alaska and Hawaii may take longer.
Out of stock
Free U.S. shipping on orders $199+
Important
Research Use Notice
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.
Product Documentation
Details, specifications, and documents
Description
Pancragen 20 mg: research material
Buy Pancragen 20 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.
Published Pancragen research describes Lys-Glu-Asp-Trp, abbreviated KEDW, in experiments on pancreatic-cell differentiation. Sequence notation and terminal chemistry are important parts of those research methods.
Choose the material and presentation
This presentation contains a labeled 20 mg of material. The 3 mL figure is the vial capacity, not a supplied liquid volume or solution concentration.
A published Pancragen study explicitly identifies an amidated form, KEDW-NH2. A free-acid terminus is chemically different. Terminal chemistry and counterions determine which molecular-weight reference applies. Record those details alongside the sequence when comparing laboratory methods.
Pancragen in pancreatic-cell research
A 2012 cell-culture study examined short peptides in several tissue models. The Pancragen experiments concerned human embryonic pancreatic cells and differentiation-associated markers, including CXCL12 and Hoxa3.
The authors reported lower marker expression in later-passage cultures and a more pronounced peptide-associated response in those cultures. Here, culture aging means repeated laboratory passage. It is not a measurement of pancreatic function or aging in people.
These observations concern differentiation-associated markers in the cell cultures studied. The study compared distinct peptides in different tissues, so results from its bronchial-cell or fibroblast experiments should not be assigned to Pancragen.
Product records
Open the Documents tab for the product files currently provided with this listing. Check that each record identifies the material and presentation you need. Where an experiment requires a batch-specific certificate, request the applicable report and confirm its lot match before relying on it.
Identity, chromatographic purity and measured content are different specifications. Storage and handling requirements also need material-specific support; another supplier’s solvent instructions or expiry period should not be treated as this vial’s specification.
Additional information
| Applications | Laboratory research |
|---|---|
| Format | Lyophilized powder |
| Appearance | Lyophilized powder |
| Safety Information | See Documents for available product files. |
COA & Documents
Independent lot testing
Pancragen 20mg Certificate of Analysis
This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.
- Lot number
- 94940
- Report number
- 40172
- Date tested
- September 23, 2026
- Reported purity
- 99.001%
- Labeled content
- 20 mg
Product documents
Product information and laboratory resources. For lot-specific results, use the COA above.
Product & packaging information
Labeled amount, physical form and packaging for Pancragen 20mg.
Revision 0.4 · 2026-10-05Download PDFLaboratory handling guide
General guidance for applicable lyophilized research materials. Not a product-specific SDS.
Revision 1.0 · 2026-09-22Download PDFGeneral guides & resources
Reading a COA & Verifying Your Lot
PDF · Revision 1.0Receiving, Storage & Traceability Record
PDF · Revision 1.0Research Use & Documentation Scope
PDF · Revision 1.0Need Assistance?
Questions about product documentation?
Contact our support team for help with product records, lot information, orders or certificate verification.
